{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:11:30Z","timestamp":1790705490371,"version":"4.1.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The current review highlights how inborn errors of immunity (IEI) due to IL-2 receptor (IL-2R) subunit defects may result in children presenting with a wide variety of infectious and inflammatory presentations beyond typical X-linked severe combined immune deficiency (X-SCID) associated with IL-2R\u03b3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Newborn screening has made diagnosis of typical SCID presenting with severe infections less common. Instead, infants are typically diagnosed in the first days of life when they appear healthy. Although earlier diagnosis has improved clinical outcomes for X-SCID, atypical SCID or other IEI not detected on newborn screening may present with more limited infectious presentations and\/or profound immune dysregulation. Early management to prevent\/control infections and reduce inflammatory complications is important for optimal outcomes of definitive therapies. Hematopoietic stem cell transplant (HSCT) is curative for IL-2R\u03b1, IL-2R\u03b2, and IL-2R\u03b3 defects, but gene therapy may yield comparable results for X-SCID.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Defects in IL-2R subunits present with infectious and inflammatory phenotypes that should raise clinician's concern for IEI. Immunophenotyping may support the suspicion for diagnosis, but ultimately genetic studies will confirm the diagnosis and enable family counseling. Management of infectious and inflammatory complications will determine the success of gene therapy or HSCT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001181","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T09:13:07Z","timestamp":1664269987000},"page":"580-588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["A great disturbance in the force: IL-2 receptor defects disrupt immune homeostasis"],"prefix":"10.1097","volume":"34","author":[{"given":"Joseph D.","family":"Hernandez","sequence":"first","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, School of Medicine, Stanford University, Lucile Packard Children's Hospital, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena W.Y.","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology, Department of Pediatrics, School of Medicine, University of Colorado, Children's Hospital Colorado, Aurora"},{"name":"University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","article-title":"Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system","volume":"17","author":"Kim","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.1117893","article-title":"Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors","volume":"310","author":"Wang","year":"2005","journal-title":"Science"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/369330a0","article-title":"Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling","volume":"369","author":"Nakamura","year":"1994","journal-title":"Nature"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/369333a0","article-title":"Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation","volume":"369","author":"Nelson","year":"1994","journal-title":"Nature"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20020190","article-title":"Interleukin 2 signaling is required for CD4(+) regulatory T cell function","volume":"196","author":"Furtado","year":"2002","journal-title":"J Exp Med"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J Exp Med"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2019.11.011","article-title":"Control of memory CD8(+) T cell longevity and effector functions by IL-15","volume":"117","author":"Nolz","year":"2020","journal-title":"Mol Immunol"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"747324","DOI":"10.3389\/fimmu.2021.747324","article-title":"Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","article-title":"Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain","volume":"2","author":"Cao","year":"1995","journal-title":"Immunity"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","article-title":"Posttransplantation B cell function in different molecular types of SCID","volume":"33","author":"Buckley","year":"2013","journal-title":"J Clin Immunol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","article-title":"IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo","volume":"118","author":"Recher","year":"2011","journal-title":"Blood"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","article-title":"Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans","volume":"73","author":"Noguchi","year":"1993","journal-title":"Cell"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","article-title":"SCID newborn screening: what we\u2019ve learned","volume":"147","author":"Currier","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients posthematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006\u20132014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2019.01908","article-title":"Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: report of the italian primary immunodeficiency network","volume":"10","author":"Cirillo","year":"2019","journal-title":"Front Immunol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10875-015-0149-1","article-title":"The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?","volume":"35","author":"Lankisch","year":"2015","journal-title":"J Clin Immunol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1542\/peds.2010-3680","article-title":"Clinical features that identify children with primary immunodeficiency diseases","volume":"127","author":"Subbarayan","year":"2011","journal-title":"Pediatrics"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.162.5.2890","article-title":"IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells","volume":"162","author":"Kolls","year":"1999","journal-title":"J Immunol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QCO.0000000000000593","article-title":"Primary immunodeficiencies and invasive fungal infection: when to suspect and how to diagnose and manage","volume":"32","author":"Lionakis","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00431-007-0527-7","article-title":"Fungal infections in primary immunodeficiencies","volume":"166","author":"Antachopoulos","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaci.2017.01.005","article-title":"Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening","volume":"139","author":"Dorsey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.bmt.1702656","article-title":"Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit","volume":"26","author":"Crooks","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","article-title":"Infections in Infants with SCID: isolation, infection screening, and prophylaxis in PIDTC centers","volume":"41","author":"Dorsey","year":"2021","journal-title":"J Clin Immunol"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaip.2021.11.032","article-title":"Long-term clinical outcomes of severe combined immunodeficiency patients given nonablative marrow transplants","volume":"10","author":"Hardin","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10875-021-01143-y","article-title":"BCG disease in SCID: three decades of experience in a pediatric transplant center","volume":"42","author":"Cocchi","year":"2022","journal-title":"J Clin Immunol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10875-021-01020-8","article-title":"A case of severe combined immunodeficiency missed by newborn screening","volume":"41","author":"Kitcharoensakkul","year":"2021","journal-title":"J Clin Immunol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex-linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10875-021-01112-5","article-title":"Hematopoietic cell transplantation for severe combined immunodeficiency patients: a japanese retrospective study","volume":"41","author":"Miyamoto","year":"2021","journal-title":"J Clin Immunol"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10875-022-01239-z","article-title":"TCRalphabeta-depleted haploidentical grafts are a safe alternative to HLA-matched unrelated donor stem cell transplants for infants with severe combined immunodeficiency","volume":"42","author":"Tsilifis","year":"2022","journal-title":"J Clin Immunol"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2019.01.030","article-title":"New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies","volume":"144","author":"Elfeky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2017-10-809822","article-title":"B-cell differentiation and IL-21 response in IL2RG\/JAK3 SCID patients after hematopoietic stem cell transplantation","volume":"131","author":"Miggelbrink","year":"2018","journal-title":"Blood"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2021.07.029","article-title":"Poor T-cell receptor beta repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution","volume":"149","author":"Delmonte","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJM199611213352104","article-title":"Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells","volume":"335","author":"Stephan","year":"1996","journal-title":"N Engl J Med"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10875-015-0202-0","article-title":"Late-onset combined immunodeficiency with a novel IL2RG mutation and probable revertant somatic mosaicism","volume":"35","author":"Okuno","year":"2015","journal-title":"J Clin Immunol"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"608653","DOI":"10.3389\/fimmu.2020.608653","article-title":"Immune reconstitution after gene therapy approaches in patients with X-linked severe combined immunodeficiency disease","volume":"11","author":"Blanco","year":"2020","journal-title":"Front Immunol"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N Engl J Med"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"97ra79","DOI":"10.1126\/scitranslmed.3002715","article-title":"Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N Engl J Med"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci Transl Med"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N Engl J Med"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2014-12-616003","article-title":"Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1","volume":"125","author":"Touzot","year":"2015","journal-title":"Blood"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coi.2021.07.010","article-title":"Clean up by aisle 2: roles for IL-2 receptors in host defense and tolerance","volume":"72","author":"Hsieh","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10875-018-0514-y","article-title":"T(+) NK(+) IL-2 receptor gamma chain mutation: a challenging diagnosis of atypical severe combined immunodeficiency","volume":"38","author":"Stepensky","year":"2018","journal-title":"J Clin Immunol"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/1346-8138.15054","article-title":"Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene","volume":"46","author":"Ibusuki","year":"2019","journal-title":"J Dermatol"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13223-018-0317-y","article-title":"IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon 8 and a review of the literature","volume":"15","author":"Lim","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.20182015","article-title":"A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation","volume":"216","author":"Fernandez","year":"2019","journal-title":"J Exp Med"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.20182304","article-title":"Human interleukin-2 receptor beta mutations associated with defects in immunity and peripheral tolerance","volume":"216","author":"Zhang","year":"2019","journal-title":"J Exp Med"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/eji.201444689","article-title":"Patients with T(+)\/low NK(+) IL-2 receptor gamma chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency","volume":"44","author":"Fuchs","year":"2014","journal-title":"Eur J Immunol"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2019.02.003","article-title":"CD25 deficiency: a new conformational mutation prevents the receptor expression on cell surface","volume":"201","author":"Vignoli","year":"2019","journal-title":"Clin Immunol"},{"key":"R63-20250730","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","article-title":"IL-2 receptor alpha deficiency and features of primary biliary cirrhosis","volume":"27","author":"Aoki","year":"2006","journal-title":"J Autoimmun"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cei.12214","article-title":"Follicular bronchiolitis as phenotype associated with CD25 deficiency","volume":"175","author":"Bezrodnik","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14785\/lpsn-2014-0003","article-title":"Pulmonary hemorrhage in a case of CD25 deficiency","volume":"01","author":"Al Sukaiti","year":"2014","journal-title":"LymphoSign J"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1073\/pnas.94.7.3168","article-title":"Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor","volume":"94","author":"Sharfe","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-20250730","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V98.3.877","article-title":"Defective expression of the interleukin-2\/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency","volume":"98","author":"Gilmour","year":"2001","journal-title":"Blood"},{"key":"R69-20250730","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.13405","article-title":"The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype","volume":"200","author":"Arcas-Garcia","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"R70-20250730","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10875-020-00745-2","article-title":"Novel hemizygous IL2RG p.(Pro58Ser) mutation impairs IL-2 receptor complex expression on lymphocytes causing X-linked combined immunodeficiency","volume":"40","author":"Elina","year":"2020","journal-title":"J Clin Immunol"},{"key":"R71-20250730","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1189\/jlb.0809566","article-title":"CD57+ T lymphocytes and functional immune deficiency","volume":"87","author":"Focosi","year":"2010","journal-title":"J Leukoc Biol"},{"key":"R72-20250730","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3389\/fimmu.2018.01429","article-title":"Primary immunodeficiencies unravel the role of IL-2\/CD25\/STAT5b in human natural killer cell maturation","volume":"9","author":"Caldirola","year":"2018","journal-title":"Front Immunol"},{"key":"R73-20250730","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051450","article-title":"CD56bright natural killer cells: a possible biomarker of different treatments in multiple sclerosis","volume":"9.","author":"Laroni","year":"2020","journal-title":"J Clin Med"},{"key":"R74-20250730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-016-0916-7","article-title":"mTOR inhibitors effects on regulatory T cells and on dendritic cells","volume":"14","author":"Stallone","year":"2016","journal-title":"J Transl Med"},{"key":"R75-20250730","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R76-20250730","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3324\/haematol.2016.153411","article-title":"Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome","volume":"102","author":"Klemann","year":"2017","journal-title":"Haematologica"},{"key":"R77-20250730","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R78-20250730","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations-10 children and review of the literature","volume":"42","author":"Deya-Martinez","year":"2022","journal-title":"J Clin Immunol"},{"key":"R79-20250730","doi-asserted-by":"crossref","first-page":"717388","DOI":"10.3389\/fimmu.2021.717388","article-title":"Emerging place of JAK inhibitors in the treatment of inborn errors of immunity","volume":"12","author":"Hadjadj","year":"2021","journal-title":"Front Immunol"},{"key":"R80-20250730","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R81-20250730","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2020.00239","article-title":"Hematopoietic cell transplantation in patients with primary immune regulatory disorders (PIRD): a primary immune deficiency treatment consortium (PIDTC) survey","volume":"11","author":"Chan","year":"2020","journal-title":"Front Immunol"},{"key":"R82-20250730","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41385-021-00423-5","article-title":"Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis","volume":"14","author":"Joosse","year":"2021","journal-title":"Mucosal Immunol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:04:58Z","timestamp":1753898698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001181","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}